January, 2005:
- Fosamax patent ruling another blow for Merck
- Greenfield Online acquires Rapidata.net
- British Medical Journal retracts Prozac report
- Cialis set for Super Bowl return
- AstraZeneca expects earnings rise despite Crestor, Exanta, Iressa questions
- MS&L opens Quebec office and names SVP
- Two Industry Veterans Launch JYT Health
- Pharma companies increase prices on popular drugs
- Johnson & Johnson sees global pharmaceutical sales jump
- Mindspan adds Jim King as VP, business development
- Final Medicare Rx benefit rules unveiled
- ISN and NPG partner to create new journal
- FDA approves 31 NMEs in 2004, 10 more than in 2003
- Mobic’s blockbuster potential follows COX-2 bad news
- Novartis to air eye Rx ad during first half of Super Bowl
- MediaVest transfer prompted by assignment concentration
- Ortho-McNeil seeks NDA for premature ejaculation drug
- Pfizer purchases Angiosyn, deal to close in first quarter
- Former Aventis executives now in new Novo Nordisk posts
- Chandler Chicco acquires Korea communications firm
- Bristol-Myers Squibb, Ventiv ink multi-year service deal
- Ogilvy and Healthworld merge to form new agency
- Journal study raises questions about Plavix
- Prounis launches new agency
- Competitive market should keep drug prices down, HHS nominee says
- CommonHealth launches new agency
- Drug Store News, NACDS to host Rx marketing event for seniors
- FDA to again decide on OTC switch for Plan B contraceptive
- Schering-Plough makes changes in its R&D operations
- FDA panel rejects OTC request for Mevacor
- J&J's Christine Poon accepts additional roles
- FDA panel considers nonprescription sale of Mevacor
- Palio makes several promotions
- FDA issues warning over Celebrex, Bextra ads
- Chandler Chicco Agency acquires Ignition Strategic Communications
- Stonefly adds five to its staff
- Big pharma launches new discount card
- Prescription drug spending slows
- AstraZeneca’s Crestor linked to a death
- Publicis Selling Solutions launches first CSO sales force
- Par taps MacPhee as new SVP, branded marketing and sales
- Legal challenge to Lipitor worries Wall Street
- Novartis taps Euro for Elidel, Lamisil med ed
- Bayer buys rights to market Levitra abroad
- New form of Taxol approved.
- Sudler & Hennessey acquires Current Medical Directions
- Consumer health exposition to focus on family caregivers
- Redi-Mail acquires PPS Medical Marketing Group
- People, Product and Agency News from the Jan. 7th MM&M News Brief
- Torre Lazur McCann names Ouimette as president
- Schering-Plough names Omnicom, Publicis to handle Rx ads
- AZ cuts 500 contract sales jobs
- Drug companies urged to improve R&D strategies
- Andrx abandons brand-name drug business
- USP issues final Medicare drug benefit plan
- Seasonale warned by FDA for ads
- McCarthy promoted at Lanmark Group
- Setback for Pfizer drug Lyrica
MM&M Articles
- McCann Health forms new global consultancy
- Alexion uses superheroes, social media to raise rare-disease awareness
- Five things for pharma marketers to know: Tuesday, September 20, 2016
- Five things for pharma marketers to know: Wednesday, September 21, 2016
- Five things for pharma marketers to know: Monday, September 19, 2016
- Merck educates doctors about biosimilars, long before it will sell one in the U.S.
- 4 trends with the potential to change behavior in the patient journey
- When it comes to professional ads, print makes its comeback
- 2016 Pharma Report: All the data in one place
- What do physicians think about biosimilars?
- The FDA approves Amgen's biosimilar version of Humira
- Five things for pharma marketers to know: Friday, September 23, 2016
- Five things for pharma marketers to know: Thursday, September 22, 2016
- Drug Pricing Will Be a Key Issue, Whether Clinton or Trump Win the Election
- The Michael J. Fox Foundation uses Facebook to recruit Ashkenazi Jews for Parkinson's study
